Palatin Technologies Inc (PTN)
0.96
+0.02
(+2.29%)
USD |
NYAM |
Nov 22, 16:00
0.9589
0.00 (0.00%)
After-Hours: 20:00
Palatin Technologies Cash from Financing (Quarterly): -0.127M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.127M |
| June 30, 2024 | 5.991M |
| March 31, 2024 | 9.136M |
| December 31, 2023 | 4.974M |
| September 30, 2023 | 0.4489M |
| June 30, 2023 | 1.008M |
| March 31, 2023 | -0.0253M |
| December 31, 2022 | 9.790M |
| September 30, 2022 | -0.0247M |
| June 30, 2022 | -0.0244M |
| March 31, 2022 | -0.0371M |
| December 31, 2021 | 0.2823M |
| September 30, 2021 | -0.2024M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.0046M |
| December 31, 2020 | -0.0113M |
| September 30, 2020 | -0.0778M |
| June 30, 2020 | -0.0186M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.3164M |
| September 30, 2019 | -1.587M |
| June 30, 2019 | 30.64M |
| March 31, 2019 | -1.00M |
| December 31, 2018 | -2.470M |
| September 30, 2018 | 0.1565M |
| Date | Value |
|---|---|
| June 30, 2018 | 1.783M |
| March 31, 2018 | -1.990M |
| December 31, 2017 | -2.007M |
| September 30, 2017 | -1.917M |
| June 30, 2017 | -1.960M |
| March 31, 2017 | -1.559M |
| December 31, 2016 | 14.38M |
| September 30, 2016 | 7.464M |
| June 30, 2016 | -0.065M |
| March 31, 2016 | -0.0065M |
| December 31, 2015 | -0.0972M |
| September 30, 2015 | 29.64M |
| June 30, 2015 | 0.0409M |
| March 31, 2015 | -0.6561M |
| December 31, 2014 | 29.21M |
| September 30, 2014 | -0.1221M |
| June 30, 2014 | -0.0132M |
| March 31, 2014 | 0.0314M |
| December 31, 2013 | -0.006M |
| September 30, 2013 | -0.0311M |
| June 30, 2013 | -0.0584M |
| March 31, 2013 | -0.0056M |
| December 31, 2012 | -0.0102M |
| September 30, 2012 | 34.37M |
| June 30, 2012 | -0.0053M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.3164M
Minimum
Dec 2019
9.790M
Maximum
Dec 2022
1.538M
Average
-0.0079M
Median
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.089M |
| iBio Inc | -0.162M |
| Theriva Biologics Inc | 3.716M |
| Oragenics Inc | 3.766M |
| Nanoviricides Inc | 1.710M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.016M |
| Free Cash Flow | -32.57M |
| Free Cash Flow Per Share (Quarterly) | -0.3535 |
| Free Cash Flow Yield | -204.1% |